Mantle Cell Lymphoma (MCL) Recruiting Phase 1 / 2 Trials for Rituximab (DB00073)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02632396Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in RemissionTreatment
NCT03740529A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLTreatment